Acute Hypoxemic Respiratory Failure
Conditions
Brief summary
All-cause hospital mortality.
Detailed description
Number of ventilator free-days (VFDs) at Day 28 (defined as days alive and free from mechanical ventilation at day 28 after intubation. For subjects ventilated >=28 days and for subjects who die, VFD is 0., Mortality at ICU and at Day 28., Duration (in days) on mechanical ventilation., Length of stay (in days) in the hospital for survivors., Time (in days) from treatment initiation to death., Proportions with viral RNA detection over time.
Interventions
DRUGDexametasona Kern Pharma 7
DRUG2 mg solución inyectable
Sponsors
Consorcio Centro De Investigacion Biomedica En Red
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause hospital mortality. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of ventilator free-days (VFDs) at Day 28 (defined as days alive and free from mechanical ventilation at day 28 after intubation. For subjects ventilated >=28 days and for subjects who die, VFD is 0., Mortality at ICU and at Day 28., Duration (in days) on mechanical ventilation., Length of stay (in days) in the hospital for survivors., Time (in days) from treatment initiation to death., Proportions with viral RNA detection over time. | — |
Countries
Spain
Outcome results
None listed